omniture
南京诺唯赞生物科技有限公司

Latest News

Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment

NANJING, China, Sept. 16, 2024 /PRNewswire/ -- Vazyme (688105.SH), a leading life science technolog...

2024-09-16 19:00 2921

Vazyme Signs Global Strategic Cooperation Agreement with Azenta

NANJING, China, May 31, 2023 /PRNewswire/ -- Vazyme (688105.SH), China's leading biotechnology comp...

2023-05-31 22:24 6249

Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future

NANJING, China, June 2, 2022 /PRNewswire/ -- Vazyme, China's leading biotechnology company, has rec...

2022-06-02 12:54 4515

Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022

DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) pa...

2022-01-28 13:00 5412

Vazyme Attends Medica 2021 in Germany to Accelerate Its Global Market Expansion

DUSSELDORF, Germany, Nov. 19, 2021 /PRNewswire/ -- Chinese biotechnology company Vazyme (688105.SH)...

2021-11-19 15:18 4489

Vazyme goes public on Shanghai Stock Exchange today

NANJING, China, Nov. 15, 2021 /PRNewswire/ -- On November 15, 2021, Nanjing Vazyme Biotech Co., Ltd...

2021-11-15 16:28 5029

Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021

DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biot...

2021-11-03 15:00 2651

Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021

DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biot...

2021-11-03 15:00 4456